PRE 14C

PRELIMINARY INFORMATION STATEMENT

Company: Amneal Pharmaceuticals, Inc.
Filed: October 11, 2019
Period of Report: October 11, 2019
Accession Number: 0001193125-19-266797

View Document ↗ View on SEC.gov ↗